Phase II AIDS Malignancy Consortium (AMC) trial of topical halofuginone in AIDS-associated Kaposi’s sarcoma (KS): clinical and biological effects using a novel intra-patient control design

• Egorin Merrill J,
• Lee Jeannette Y,
• Fingleton Barbara,
• Krown Susan E,
• Koon Henry B

Affiliations

Egorin Merrill J

Lee Jeannette Y

Fingleton Barbara

Krown Susan E

Koon Henry B